GSA Capital Partners’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-62,326
| Closed | -$1.13M | – | 1784 |
|
|
2025
Q1 | $1.13M | Buy |
+62,326
| New | +$1.13M | 0.1% | 288 |
|
|
2024
Q4 | – | Sell |
-16,114
| Closed | -$548K | – | 1652 |
|
|
2024
Q3 | $548K | Buy |
16,114
+10,581
| +191% | +$360K | 0.04% | 848 |
|
|
2024
Q2 | $205K | Sell |
5,533
-1,508
| -21% | -$55.9K | 0.01% | 1447 |
|
|
2024
Q1 | $296K | Buy |
+7,041
| New | +$296K | 0.02% | 1224 |
|
|
2023
Q4 | – | Sell |
-44,716
| Closed | -$1.23M | – | 1541 |
|
|
2023
Q3 | $1.23M | Buy |
44,716
+29,404
| +192% | +$809K | 0.11% | 298 |
|
|
2023
Q2 | $520K | Sell |
15,312
-9,630
| -39% | -$327K | 0.05% | 708 |
|
|
2023
Q1 | $897K | Buy |
+24,942
| New | +$897K | 0.09% | 373 |
|
|
2022
Q4 | – | Sell |
-11,116
| Closed | -$312K | – | 1516 |
|
|
2022
Q3 | $312K | Buy |
+11,116
| New | +$312K | 0.04% | 899 |
|
|
2022
Q1 | – | Sell |
-18,726
| Closed | -$724K | – | 1467 |
|
|
2021
Q4 | $724K | Buy |
+18,726
| New | +$724K | 0.09% | 368 |
|
|
2021
Q3 | – | Sell |
-9,769
| Closed | -$327K | – | 1473 |
|
|
2021
Q2 | $327K | Buy |
+9,769
| New | +$327K | 0.04% | 898 |
|
|
2019
Q1 | – | Sell |
-52,617
| Closed | -$156K | – | 1453 |
|
|
2018
Q4 | $156K | Sell |
52,617
-32,083
| -38% | -$95.1K | 0.02% | 1155 |
|
|
2018
Q3 | $573K | Buy |
84,700
+42,047
| +99% | +$284K | 0.03% | 1000 |
|
|
2018
Q2 | $322K | Buy |
+42,653
| New | +$322K | 0.02% | 1359 |
|
|
2015
Q3 | – | Sell |
-6,938
| Closed | -$2.63M | – | 1772 |
|
|
2015
Q2 | $2.63M | Buy |
6,938
+3,254
| +88% | +$1.23M | 0.1% | 218 |
|
|
2015
Q1 | $1.54M | Buy |
+3,684
| New | +$1.54M | 0.06% | 522 |
|
|
2014
Q2 | – | Sell |
-803
| Closed | -$213K | – | 1818 |
|
|
2014
Q1 | $213K | Sell |
803
-1,464
| -65% | -$388K | 0.02% | 1344 |
|
|
2013
Q4 | $823K | Sell |
2,267
-1,366
| -38% | -$496K | 0.07% | 482 |
|
|
2013
Q3 | $1.93M | Buy |
3,633
+12
| +0.3% | +$6.38K | 0.15% | 130 |
|
|
2013
Q2 | $848K | Buy |
+3,621
| New | +$848K | 0.1% | 272 |
|